Glenmark Life Sciences informs about monitoring agency report

12 Aug 2022 Evaluate

Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capita land Disclosure Requirements) Regulations, 2018, Glenmark Life Sciences has informed that it enclosed Monitoring Agency Report issued by HDFC Bank, Monitoring Agency, for the quarter ended 30th June, 2022 in respect of utilization of proceeds of the IPO of the Company.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

913.10 -7.00 (-0.76%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×